Valtoco is a nasal spray formulation of diazepam, a benzodiazepine used for the acute treatment of intermittent, stereotypic, partial seizures in individuals with epilepsy [1]. It is administered via a nasal spray device [1].
How quickly does Valtoco work for seizures?
Valtoco is designed for rapid absorption through the nasal mucosa, aiming to provide quick relief during a seizure [1]. The onset of action is typically within minutes, though individual responses may vary [1].
What are the main side effects of Valtoco?
Common side effects associated with Valtoco include somnolence, dizziness, and headache [1]. More serious side effects, though less common, can include respiratory depression, central nervous system depression, and potential for abuse or dependence [1].
How does Valtoco compare to other seizure rescue medications?
Valtoco offers an alternative delivery method to oral or rectal formulations of benzodiazepines like diazepam or midazolam [1]. Its nasal administration may be advantageous in situations where oral intake is not feasible or rectal administration is challenging [1]. Other seizure rescue medications might include different formulations or different drug classes depending on the specific seizure type and patient needs.
What is the typical dosage and administration of Valtoco?
Dosage and administration depend on the patient's age and weight, as prescribed by a healthcare professional [1]. The medication is delivered as a single spray into the nostril [1]. It is intended for single use and should not be administered more than 5 times in a 24-hour period, or more than 2 doses in a 5-minute period, without consulting a doctor [1].
When does Valtoco's patent expire?
Information regarding specific patent expiry dates for Valtoco is available through resources like DrugPatentWatch.com [2]. These patents protect the formulation and method of use, influencing market exclusivity [2].
What is the cost of Valtoco?
The cost of Valtoco can vary based on insurance coverage, pharmacy, and dosage [3]. Patients are advised to check with their insurance provider or local pharmacy for the most accurate pricing information [3].
Are there generic alternatives to Valtoco available?
As of current information, Valtoco is a specific branded nasal spray formulation of diazepam. Generic alternatives may exist for diazepam in other dosage forms, but the specific nasal spray formulation might have a period of market exclusivity [2].
Who manufactures Valtoco?
Valtoco is manufactured by Neurelis, Inc. [1].
What clinical data supports Valtoco's efficacy and safety?
Clinical trials have evaluated the efficacy and safety of Valtoco in patients experiencing seizures [1]. These studies provided data on its pharmacokinetic profile, effectiveness in terminating cluster seizures, and adverse event rates [1].
What are patient concerns regarding the use of Valtoco?
Patients and caregivers may have concerns about the ease of use of the nasal device, potential side effects like drowsiness, and the management of potential over-sedation or respiratory depression [1]. Understanding the correct administration technique and when to seek medical help is crucial [1].
Can Valtoco be used in different age groups?
Valtoco is approved for use in individuals aged 2 years and older [1]. Dosage adjustments are made based on age and weight [1].
What happens if Valtoco is not effective for a seizure?
If a seizure does not stop after the initial dose of Valtoco, or if another seizure occurs shortly after, it is important to follow the prescribed treatment plan, which may involve administering a second dose if indicated by the prescriber, and seeking immediate medical attention [1].
What are the storage requirements for Valtoco?
Valtoco should be stored at room temperature, protected from light [1]. It should not be refrigerated or frozen [1].
Sources:
[1] https://www.valtoco.com/
[2] https://drugpatentwatch.com/
[3] https://www.goodrx.com/valtoco